Recommendation of the President – determination of estriol

On 15 October 2024, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 111/2024 on the rationale for removing from the list of guaranteed benefits in the scope of the Prenatal Testing Program for determination of estriol

Publication in Public Information Bulletin (BIP) >>